AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16366195 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 11756319 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (2,550 mg/day)
Number of subjects: 0
Study 11756319 — intervention group
Group type: EXPERIMENTAL
Intervention: Troglitazone (600 mg/day)
Number of subjects: 0
Study 9640715 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-ophthalmology system initial assessment
Number of subjects: 100
Study 9640715 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face re-examination by the same ophthalmologist
Number of subjects: 100
Study 8074951 — intervention group
Group type: EXPERIMENTAL
Intervention: Fissure sealants
Number of subjects: 4294
Study 2572617 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine (10 mg once daily)
Number of subjects: 317
Study 2572617 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine (60 mg twice daily)
Number of subjects: 317
Study 2572617 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 317
Study 62266 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet of polyunsaturated fats (linoleic acid)
Number of subjects: 19
Study 62266 — intervention group
Group type: COMPARATOR
Intervention: Normal diet (Control)
Number of subjects: 19
Study 29718901 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program consisting of 2 lectures, 1 video contact, group discussion of 5 myths about depression, posters, and brochure.
Number of subjects: 360
Study 29718901 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 360
Study 27989865 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical debridement + adjunct antimicrobial photodynamic therapy (MD + aPDT)
Number of subjects: 60
Study 27989865 — intervention group
Group type: COMPARATOR
Intervention: Mechanical debridement alone (MD)
Number of subjects: 60
Study 27989865 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (MD + aPDT and MD)
Number of subjects: 60
Study 22909270 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium bisglycinate chelate (300 mg per day)
Number of subjects: 86
Study 22909270 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study 23232147 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal time of day testing (n = 21 for each age group)
Number of subjects: 84
Study 23232147 — intervention group
Group type: COMPARATOR
Intervention: Non-optimal time of day testing (n = 21 for each age group)
Number of subjects: 84
Study 23232147 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal time of day testing
Number of subjects: 84
Study 21906456 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil group (propofol at Ce of 6 μg/ml and remifentanil at Ce of 5 ng/ml)
Number of subjects: 100
Study 21906456 — intervention group
Group type: COMPARATOR
Intervention: Control group (propofol at Ce of 6 μg/ml and rocuronium 0.8 mg/kg)
Number of subjects: 100
Study 17604004 — intervention group
Group type: EXPERIMENTAL
Intervention: Pergolide (0.125 mg) before 1 Hz rTMS
Number of subjects: 9
Study 17604004 — intervention group
Group type: COMPARATOR
Intervention: Placebo before 1 Hz rTMS
Number of subjects: 9
Study 17604004 — intervention group
Group type: EXPERIMENTAL
Intervention: Pergolide (0.125 mg) before sham rTMS
Number of subjects: 9
Study 16427122 — intervention group
Group type: EXPERIMENTAL
Intervention: Silane treatment (Monobond S, Ivoclar Vivadent)
Number of subjects: 54
Study 16427122 — intervention group
Group type: COMPARATOR
Intervention: No silane treatment
Number of subjects: 54
Study 16427122 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronal third of the root
Number of subjects: 54
Study 16427122 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium third of the root
Number of subjects: 54
Study 16427122 — intervention group
Group type: EXPERIMENTAL
Intervention: Type of post (DT, FR, PP)
Number of subjects: 54
Study 14765004 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD group
Number of subjects: 11
Study 14765004 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 11
Study 9894381 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 0
Study 9894381 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antiarrhythmic therapy
Number of subjects: 0
Study 7878805 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) as an adjunct to cyclosporine-based immunosuppression
Number of subjects: 0
Study 1973942 — intervention group
Group type: COMPARATOR
Intervention: Gepirone (5-30 mg/day)
Number of subjects: 0
Study 1973942 — intervention group
Group type: COMPARATOR
Intervention: Gepirone (continuation therapy after 6 weeks of open therapy)
Number of subjects: 0
Study 1973942 — intervention group
Group type: COMPARATOR
Intervention: Gepirone
Number of subjects: 0
Study 28070 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 50
Study 28070 — intervention group
Group type: COMPARATOR
Intervention: Pindolol
Number of subjects: 50
Study 31523041 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI scoring of bone marrow edema (BME)
Number of subjects: 441
Study 31523041 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI scoring of synovitis
Number of subjects: 441
Study 31523041 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI scoring of tenosynovitis
Number of subjects: 441
Study 31523041 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI scoring of erosions
Number of subjects: 441
Study 31523041 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrareader reliability for inflammatory MRI features
Number of subjects: 441
Study 31523041 — intervention group
Group type: EXPERIMENTAL
Intervention: Change-score ICCs
Number of subjects: 441
Study 31523041 — intervention group
Group type: EXPERIMENTAL
Intervention: Smallest detectable changes (SDC)
Number of subjects: 441
Study 31523041 — intervention group
Group type: EXPERIMENTAL
Intervention: Reliability of MTP-joint MRI scores compared to MCP and wrist joints
Number of subjects: 441
Study 28740085 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol self‐dosing
Number of subjects: 88
Study 28740085 — intervention group
Group type: COMPARATOR
Intervention: Sober condition
Number of subjects: 88
Study 24577643 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental Shuttle Walk Test (ISWT)
Number of subjects: 16
Study 24577643 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental Treadmill Test (ITMT)
Number of subjects: 16
Study 24577643 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-Minute Walk Test (6MWT)
Number of subjects: 16
Study 22421693 — intervention group
Group type: EXPERIMENTAL
Intervention: Circumcision
Number of subjects: 526
Study 22421693 — intervention group
Group type: COMPARATOR
Intervention: Uncircumcision
Number of subjects: 526
Study 19439989 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylcysteine (5 g in 5% glucose in a final volume of 50 ml) administered intravenously during hemodialysis
Number of subjects: 24
Study 19439989 — intervention group
Group type: COMPARATOR
Intervention: No acetylcysteine (placebo)
Number of subjects: 24
Study 18158671 — intervention group
Group type: EXPERIMENTAL
Intervention: Role-playing during technical skills training
Number of subjects: 36
Study 18158671 — intervention group
Group type: COMPARATOR
Intervention: No role-playing during technical skills training
Number of subjects: 36
Study 15142699 — intervention group
Group type: EXPERIMENTAL
Intervention: Lengthening of the flexor retinaculum
Number of subjects: 26
Study 15142699 — intervention group
Group type: COMPARATOR
Intervention: Simple division of the flexor retinaculum
Number of subjects: 26
Study 11942713 — intervention group
Group type: EXPERIMENTAL
Intervention: Community changes facilitated by a community health initiative to prevent adolescent pregnancy
Number of subjects: 0
Study 9617705 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic stimulation of the brain and cervical and lumbar spinal roots
Number of subjects: 48
Study 7714222 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg/day buspirone
Number of subjects: 44
Study 7714222 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 7714222 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 44
Study 2655688 — intervention group
Group type: EXPERIMENTAL
Intervention: ICI 169, 369 (10, 30, and 50 mg)
Number of subjects: 0
Study 2655688 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 342302 — intervention group
Group type: EXPERIMENTAL
Intervention: Lunerin Mixture, Lunerin Mite
Number of subjects: 0
Study 342302 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30885194 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined high-intensity interval training (HIIT) with resistance training (RT)
Number of subjects: 80
Study 30885194 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined moderate continuous training (MCT) with resistance training (RT)
Number of subjects: 80
Study 30885194 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study 29173304 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.6 mg/kg/dose, 2 doses)
Number of subjects: 590
Study 29173304 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone/prednisone (1.5 mg/kg/d for 1 day, followed by 1 mg/kg/d on days 2‐5)
Number of subjects: 590
Study 25537065 — intervention group
Group type: EXPERIMENTAL
Intervention: Sport goggles (G)
Number of subjects: 3
Study 25537065 — intervention group
Group type: COMPARATOR
Intervention: No goggles (NG)
Number of subjects: 3
Study 23599075 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency (1 Hz) 110% motor threshold rTMS for 4 weeks
Number of subjects: 14
Study 23599075 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS for 4 weeks
Number of subjects: 14
Study 23599075 — intervention group
Group type: COMPARATOR
Intervention: Comparison of active rTMS vs sham rTMS
Number of subjects: 14
Study 21349458 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 17393
Study 21349458 — intervention group
Group type: COMPARATOR
Intervention: Heparin + glycoprotein IIb/IIIa inhibitor
Number of subjects: 17393
Study 21349458 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonaccess site bleeding
Number of subjects: 17393
Study 21349458 — intervention group
Group type: EXPERIMENTAL
Intervention: Access site bleeding
Number of subjects: 17393
Study 19770609 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulfillment of specific items on the Internal Validity Checklist
Number of subjects: 216
Study 19770609 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulfillment of 5 or 6 items on the Internal Validity Checklist
Number of subjects: 216
Study 19770609 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher scores on the Internal Validity Checklist
Number of subjects: 216
Study 17209059 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day 2-CdA protocol
Number of subjects: 132
Study 17209059 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 weekly 2-CdA infusions
Number of subjects: 132
Study 16942627 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy (PT) twice daily sessions
Number of subjects: 0
Study 16942627 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy (PT) once daily sessions
Number of subjects: 0
Study 12940794 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aid
Number of subjects: 207
Study 12940794 — intervention group
Group type: COMPARATOR
Intervention: Pamphlet
Number of subjects: 207
Study 10679885 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus an educational intervention
Number of subjects: 266
Study 10679885 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 266
Study 8754291 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic plasma
Number of subjects: 0
Study 8754291 — intervention group
Group type: COMPARATOR
Intervention: Control plasma
Number of subjects: 0
Study 8754291 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-inactivated diabetic plasma
Number of subjects: 0
Study 8754291 — intervention group
Group type: EXPERIMENTAL
Intervention: Zymosan-activated diabetic plasma
Number of subjects: 0
Study 8754291 — intervention group
Group type: EXPERIMENTAL
Intervention: FMLP solution
Number of subjects: 0
Study 1941404 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous bolus infusion of 10% calcium gluconate
Number of subjects: 36
Study 1941404 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous bolus infusion of 5% calcium gluconate
Number of subjects: 36
Study 1941404 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous bolus infusion of calcium gluconate (both 5% and 10%)
Number of subjects: 36
Study 7009993 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapleural BCG immunotherapy
Number of subjects: 169
Study 7009993 — intervention group
Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 169
Study 31629637 — intervention group
Group type: EXPERIMENTAL
Intervention: TachoSil binding suturing technique
Number of subjects: 113
Study 31629637 — intervention group
Group type: COMPARATOR
Intervention: Conventional suturing without TachoSil
Number of subjects: 113
Study 31572763 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral care protocol
Number of subjects: 70
Study 31572763 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 70
Study 28407726 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT) plus active Attention Bias Modification Therapy (ABMT)
Number of subjects: 54
Study 28407726 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-Behavioral Therapy (CBT) plus placebo Attention Bias Modification Therapy (ABMT)
Number of subjects: 54
Study 26329852 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-cooling for 2 min before plain lidocaine injection
Number of subjects: 60
Study 26329852 — intervention group
Group type: COMPARATOR
Intervention: Buffered lidocaine injection
Number of subjects: 60
Study 26329852 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-cooling group
Number of subjects: 60
Study 26329852 — intervention group
Group type: COMPARATOR
Intervention: Buffered lidocaine group
Number of subjects: 60
Study 26329852 — intervention group
Group type: COMPARATOR
Intervention: Pre-cooling and buffered lidocaine
Number of subjects: 60
Study 24009042 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel (10 mg)
Number of subjects: 194
Study 24009042 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (75 mg)
Number of subjects: 194
Study 20972299 — intervention group
Group type: EXPERIMENTAL
Intervention: Short course of antibiotics (48 to 96 hours)
Number of subjects: 52
Study 20972299 — intervention group
Group type: COMPARATOR
Intervention: 7-day course of antibiotics
Number of subjects: 52
Study 19260871 — intervention group
Group type: EXPERIMENTAL
Intervention: FENO guided therapy
Number of subjects: 5
Study 19260871 — intervention group
Group type: COMPARATOR
Intervention: Standard asthma therapy
Number of subjects: 5
Study 17288655 — intervention group
Group type: EXPERIMENTAL
Intervention: Store-and-forward teledermatology
Number of subjects: 508
Study 17288655 — intervention group
Group type: COMPARATOR
Intervention: Usual care (conventional clinic-based dermatology appointment)
Number of subjects: 508
Study 15479681 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotic carbohydrates (7.5 g of oligofructose and 7.5 g inulin)
Number of subjects: 29
Study 15479681 — intervention group
Group type: COMPARATOR
Intervention: Control (no supplement)
Number of subjects: 29
Study 11777121 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual cognitive-behavioral therapy (CBT)
Number of subjects: 63
Study 11777121 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 63
Study 11777121 — intervention group
Group type: COMPARATOR
Intervention: Supportive-expressive group therapy (SEG)
Number of subjects: 63
Study 11777121 — intervention group
Group type: EXPERIMENTAL
Intervention: Hamilton Rating Scale for Depression
Number of subjects: 63
Study 11777121 — intervention group
Group type: EXPERIMENTAL
Intervention: Beck Depression Inventory (BDI)
Number of subjects: 63
Study 11777121 — intervention group
Group type: EXPERIMENTAL
Intervention: BDI-18
Number of subjects: 63
Study 9135184 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimanual cricoid pressure
Number of subjects: 94
Study 9135184 — intervention group
Group type: COMPARATOR
Intervention: Single-handed cricoid pressure
Number of subjects: 94
Study 9135184 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of both techniques
Number of subjects: 94
Study 7951548 — intervention group
Group type: EXPERIMENTAL
Intervention: Methimazole (MMI) treatment in untreated patients with low thyroid CT number
Number of subjects: 60
Study 7951548 — intervention group
Group type: EXPERIMENTAL
Intervention: Methimazole (MMI) treatment in patients with normal thyroid CT number prior to therapy
Number of subjects: 60
Study 7951548 — intervention group
Group type: COMPARATOR
Intervention: Hyperthyroid Graves' disease
Number of subjects: 60
Study 7951548 — intervention group
Group type: COMPARATOR
Intervention: Euthyroid Graves' disease
Number of subjects: 60
Study 7951548 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 60
Study 3038156 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nafazatrom (Bay g6575, 2 X 3 g)
Number of subjects: 4
Study 3038156 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 31811542 — intervention group
Group type: EXPERIMENTAL
Intervention: Myofunctional therapy support program (MTSP) for 12 weeks
Number of subjects: 31
Study 31811542 — intervention group
Group type: COMPARATOR
Intervention: One education session of myofunctional therapy (control)
Number of subjects: 31
Study 31864351 — intervention group
Group type: EXPERIMENTAL
Intervention: Support packages for adolescent girls on early childbearing
Number of subjects: 16
Study 31864351 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomisation process
Number of subjects: 16
Study 28051345 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 × 16 min HIIT sessions
Number of subjects: 63
Study 28051345 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 × 8 min HIIT sessions
Number of subjects: 63
Study 28051345 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 × 4 min HIIT sessions
Number of subjects: 63
Study 26103794 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring group (n = 18)
Number of subjects: 37
Study 26103794 — intervention group
Group type: COMPARATOR
Intervention: Usual care group (n = 19)
Number of subjects: 37
Study 23128579 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensor-augmented pump therapy (SAPT)
Number of subjects: 483
Study 23128579 — intervention group
Group type: COMPARATOR
Intervention: Multiple daily injections of insulin (MDI)
Number of subjects: 483
Study 21982167 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia with propofol and remifentanil (PR group)
Number of subjects: 40
Study 21982167 — intervention group
Group type: COMPARATOR
Intervention: Inhalational anesthesia with sevoflurane (S group)
Number of subjects: 40
Study 19568596 — intervention group
Group type: EXPERIMENTAL
Intervention: Post swim-up acrosome index considered (Group I)
Number of subjects: 50
Study 19568596 — intervention group
Group type: COMPARATOR
Intervention: Post swim-up acrosome index not considered (Group II)
Number of subjects: 50
Study 16924017 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with autism spectrum disorder (ASD)
Number of subjects: 60
Study 16924017 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with developmental delay (DD)
Number of subjects: 60
Study 16924017 — intervention group
Group type: COMPARATOR
Intervention: Children with typical development (TD)
Number of subjects: 60
Study 15680096 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment (open reduction and internal fixation using a standard lateral approach)
Number of subjects: 41
Study 15680096 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment (ice and elevation)
Number of subjects: 41
Study 15680096 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 41
Study 15680096 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 41
Study 12067850 — intervention group
Group type: EXPERIMENTAL
Intervention: DCA infusion (100 mg/kg body wt)
Number of subjects: 8
Study 12067850 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperoxic breathing (100% O2)
Number of subjects: 8
Study 12067850 — intervention group
Group type: COMPARATOR
Intervention: Control (normoxic breathing and saline infusion)
Number of subjects: 8
Study 9876731 — intervention group
Group type: EXPERIMENTAL
Intervention: Nizatidine 100 mg intravenously
Number of subjects: 40
Study 9876731 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 40
Study 7900703 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous fluorouracil infusion (FUcont)
Number of subjects: 129
Study 7900703 — intervention group
Group type: COMPARATOR
Intervention: Bolus fluorouracil plus leucovorin (FU‐FA)
Number of subjects: 129
Study 7900703 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life evaluation using linear analogue scales
Number of subjects: 129
Study 2612552 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive warfarin maintenance dosing technique
Number of subjects: 43
Study 2612552 — intervention group
Group type: COMPARATOR
Intervention: Empirical dosing method
Number of subjects: 43
Study 863344 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 91
Study 863344 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 91
Study 31526296 — intervention group
Group type: EXPERIMENTAL
Intervention: E-Course (two 15-minute online classes per week for 3 weeks)
Number of subjects: 144
Study 31526296 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 144
Study 28187765 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheumatoid arthritis patients
Number of subjects: 50
Study 26381151 — intervention group
Group type: EXPERIMENTAL
Intervention: SBT+SE
Number of subjects: 130
Study 26381151 — intervention group
Group type: COMPARATOR
Intervention: SBT
Number of subjects: 130
Study 23377391 — intervention group
Group type: EXPERIMENTAL
Intervention: MaxClarity
Number of subjects: 40